Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity
- 119 Downloads
Administration of triacetyluridine (TAU) is a means of delivering exogenous pyrimidines to the brain, which may help to compensate for bioenergetic defects. TAU has previously been shown to be neuroprotective in animal models of Huntington’s and Alzheimer’s diseases. We examined whether oral administration of TAU in the diet could exert significant neuroprotective effects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity model of Parkinson’s disease. Administration of TAU significantly attenuated MPTP-induced depletion of striatal dopamine and loss of tyrosine-hydroxylase-positive neurons in the substantia nigra. These findings suggest that administration of TAU may be a novel approach for treating neurodegenerative diseases associated with impaired mitochondrial function.
Index EntriesParkinson’s disease mitochondria MPTP triacetyluridine dopamine
Unable to display preview. Download preview PDF.
- Beal M. F., Matthews R. T., Tieleman A., and Shults C. W. (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3, tetrahydropyridine (MPTP) induced loss of striatal dopamine axons in aged mice. Brain Res. 157, 142–149.Google Scholar
- Garcia R. A. G., Hu Z. Y., Liu L. S., Noble M., von Borstel R. W., and Saydoff J. A. (2002) Neuroprotective doses of PN401 that produce supraphysiological levels of uridine are greater than the dose of PN401 required to correct a pyrimidine deficiency. Soc. Neurosci. 27, 685.615.Google Scholar
- Saydoff J. A., Liu L. S., Garcia R. A. G., Hu Z., Li D., and von Borstel R.W. (2003) Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington’s Disease. Brain Res. 994, 44–54.PubMedCrossRefGoogle Scholar
- Saydoff J. A., Liu L. S., Hu Z. Y., et al. (2001) Oral uridine Pro-drug P N 401 protects against azide toxicity in vivo: studies on the mechanism of uridine neuroprotection in vitro. Soc. Neurosci. 27, 2360.Google Scholar